Introduction by the Guest Editors: The PD-1 Axis in Cancer Therapy: The Irony in a Name

Cancer J. 2018 Jan/Feb;24(1):1. doi: 10.1097/PPO.0000000000000305.
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antineoplastic Agents, Immunological / therapeutic use
  • DNA Mismatch Repair / drug effects
  • Humans
  • Ligands
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism
  • Programmed Cell Death 1 Receptor / metabolism*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • Ligands
  • Programmed Cell Death 1 Receptor
  • pembrolizumab